--BRT Apartments Keeps Quarterly Dividend at $0.25 a Share, Payable July 9 to Shareholders of Record June 25-March 2024-www.financetom.com

--BRT Apartments Keeps Quarterly Dividend at $0.25 a Share, Payable July 9 to Shareholders of Record June 25

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--BRT Apartments Keeps Quarterly Dividend at $0.25 a Share, Payable July 9 to Shareholders of Record June 25

Jun 11, 2024 8:24 AM

11:03 AM EDT, 06/11/2024 (MT Newswires) --

Price: 17.94, Change: +0.03, Percent Change: +0.17

Previous page： Bitcoin vs Dogecoin: All you need to know about these cryptocurrencies Next page： Reliance Q4FY21 preview: Overall revenue growth of 23% QoQ expected

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bitcoin vs Dogecoin: All you need to know about these cryptocurrencies

Apr 29, 2021

One of the biggest differences between the two crypto currencies is the number of Bitcoins that can be created is capped at 21 million and currently there are 18.7 million in circulation. Dogecoin, on the other hand, has no limit and there are now nearly 130 billion Dogecoin tokens in existence.

Reliance Q4FY21 preview: Overall revenue growth of 23% QoQ expected

Apr 29, 2021

The other segmental performance contribution to the topline - retail will be about mid-single-digit QoQ growth while Jio will report a decline in their revenues quarter on quarter.

Explained: How Elon Musk contributed to the rise of 'meme cryptocurrency' Dogecoin

Apr 29, 2021

Telsa chief Elon Musk has been backing dog-themed cryptocurrency 'Dogecoin' through his numerous tweets. This has led to investor interest and a surge in its value. Musk now wants to buy out major holders.

Biocon confident of delivering stronger biosimilar growth in FY22: Kiran Mazumdar Shaw

Apr 29, 2021

Biocon reported its Q4FY21 earnings on Wednesday. Detailing the numbers, Kiran Mazumdar Shaw, Executive Chairperson of the company, said they have seen some headwinds in biosimilars but is confident of delivering a stronger biosimilar growth in FY22.